Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.67 |
| ▸ | CA2 | P00918 | 13/20 | 0.67 |
| ▸ | F2 | P00734 | 3/20 | 0.62 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.62 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.62 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.62 |
| ▸ | CA9 | Q16790 | 9/20 | 0.61 |
| ▸ | CA12 | O43570 | 6/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.59 |
| ▸ | CA6 | P23280 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CA3 | P07451 | 2/20 | 0.59 |
| ▸ | CA5A | P35218 | 2/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | IL1RN | P18510 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31670545 | 1.00 | CA1 (0.67) | CA1CA2F2PRSS1PRSS2 | |
| SCHEMBL11802407 | 0.88 | CA1 (0.55) | CA1CA2F2PRSS1PRSS2 | |
| SCHEMBL7913940 | 0.86 | CA1 (0.64) | CA1CA2CA9CA12CA14 | |
| SCHEMBL9796322 | 0.85 | CA2 (0.64) | CA1CA2CA9CA12CA14 | |
| SCHEMBL30230622 | 0.84 | CA2 (0.61) | CA1CA2F2PRSS1PRSS2 | |
| SCHEMBL1805285 | 0.84 | CA2 (0.61) | CA1CA2F2PRSS1PRSS2 | |
| SCHEMBL2405304 | 0.83 | F2 (0.61) | CA1CA2F2PRSS1PRSS2 | |
| SCHEMBL29964265 | 0.83 | F2 (0.61) | CA1CA2F2PRSS1PRSS2 | |
| SCHEMBL1805282 | 0.82 | CA2 (0.59) | CA1CA2CA9CA12CA14 | |
| SCHEMBL10589468 | 0.82 | CA2 (0.59) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 841 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118146736-A | Light conversion adhesive film and preparation method and application thereof | 极电光能有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-115260326-B | Method for texturing surface of monocrystalline silicon by using alkali | 绍兴拓邦新能源股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-108863860-B | N-substituted phenyl-3-sulfonyl aminobenzamide compound, preparation thereof and application thereof in resisting breast cancer activity | 温州医科大学 | 2021-08-06 | — | — | CN | claimed |
| EP-3551633-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2021-03-31 | — | — | EP | claimed |
| CN-110088108-A | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 利奥制药有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-108863860-A | A kind of application of N- substituted-phenyl -3- sulphonamidobenzamide class compound and its preparation and anti-breast cancer activity | 温州医科大学 | 2018-11-23 | — | — | CN | claimed |
| CN-108341765-A | A kind of preparation method of the high-purity Sulpiride of environmental protection | 大桐制药（中国）有限责任公司 | 2018-07-31 | — | — | CN | claimed |
| JP-2011527302-A | — | — | 2011-10-27 | — | — | JP | claimed |
| US-20110178052-A1 | 9-ALPHA ESTRATRIENE DERIVATIVES AS ER-BETA SELECTIVE LIGANDS FOR THE PREVENTION AND TREATMENT OF INTESTINAL CANCER | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-07-21 | — | — | US | claimed |
| EP-1957514-A1 | PRODRUGS OF ER-BETA-SELECTIVE SUBSTANCES METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-08-20 | — | — | EP | claimed |
| CN-101033206-A | Method of preparing 2-chloro-3-nitro-5-carboxyl benzenesulfonamide | SUZHOU LIXIN PHARMACY CO LTD (CN) | 2007-09-12 | — | — | CN | claimed |
| WO-2007062876-A1 | PRODRUGS OF ER-BETA-SELECTIVE SUBSTANCES METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-06-07 | — | — | WO | claimed |
| EP-1747229-A1 | STEROID PRODRUGS WITH ANDROGENIC EFFECT | Schering Aktiengesellschaft (DE) | 2007-01-31 | — | — | EP | claimed |
| EP-1747231-A1 | AMINOSULPHONYL- OR AMINOSULPHONYLAMINO-SUBSTITUTED PHENYL ESTERS AS ESTRIOL AND ESTETROL PRODRUGS | Schering Aktiengesellschaft (DE) | 2007-01-31 | — | — | EP | claimed |
| WO-2005113575-A1 | STEROID PRODRUGS WITH ANDROGENIC EFFECT | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-12-01 | — | — | WO | claimed |
| WO-2005113576-A1 | AMINOSULPHONYL- OR AMINOSULPHONYLAMINO-SUBSTITUTED PHENYL ESTERS AS ESTRIOL AND ESTETROL PRODRUGS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-12-01 | — | — | WO | claimed |
| US-5480760-A | SULFONAMIDE THERMAL SOLVENT FOR IMPROVED DIFFUSION TRANSFER | EASTMAN KODAK COMPANY (US) | 1996-01-02 | — | — | US | claimed |
| US-4161531-A | Diuretic and saluretic 5-sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-07-17 | — | — | US | claimed |
| US-4010273-A | DIURETICS, SALURETICS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-03-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178052-A1 | 9-ALPHA ESTRATRIENE DERIVATIVES AS ER-BETA SELECTIVE LIGANDS FOR THE PREVENTION AND TREATMENT OF INTESTINAL CANCER | ESR2, ESRRA, ESRRG | CA1 2460/4885CA2 4348/4885F2 3562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.